First Citizens BancShares Inc (Delaware)
FCNCA · NASDAQ
About FCNCA
- Employees
- 17,876
- Headquarters
- Raleigh, North Carolina
- Listed
- Oct 22, 1986
- Sector
- Financials
- Industry
- Banks
- Website
- firstcitizens.com
FCNCA key statistics
- Market cap
- 23.24B
- Price-earnings ratio
- 11.23
- Dividend yield
- 0.79%
- Average volume
- 60.72K
- Volume
- 68.08K
- Open price
- $2,091.32
- High today
- $2,151.14
- Low today
- $2,091.32
- 52 Week high
- $2,296.30
- 52 Week low
- $1,706.10
First Citizens BancShares Inc (Delaware) (FCNCA) at a glance
First Citizens BancShares Inc (Delaware) (FCNCA) last traded at $2,120.39, with a market cap of 23.24B, a price-to-earnings ratio of 11.23 and a dividend yield of 0.79%.
Today the stock has traded between $2,091.32 and $2,151.14. The current price is 1.4% above the day's low and 1.4% below its high.
Volume so far is 68.08K shares, in line with the average of 60.72K shares a day.
Over the past year First Citizens BancShares Inc (Delaware) has ranged from $1,706.10 to $2,296.30, and now sits 70% of the way up that range.
First Citizens BancShares Inc (Delaware) met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $57.09 per share against an estimate of $41.75.
The average analyst price target is $2,375.97, 12.1% above the current price, from 11 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy27.3%
- Hold72.7%
- Sell0.0%
- Low
- $2,121.00
- Now
- $2,120.39
- High
- $2,651.25
FCNCA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 13.0% on average.
- Q3 FY24: reported $45.87 per share against an estimate of $48.82
- Q4 FY24: reported $45.10 per share against an estimate of $40.41
- Q1 FY25: reported $37.79 per share against an estimate of $39.04
- Q2 FY25: reported $42.36 per share against an estimate of $40.49
- Q3 FY25: reported $43.08 per share against an estimate of $43.23
- Q4 FY25: reported $45.81 per share against an estimate of $45.23
- Q1 FY26: reported $44.86 per share against an estimate of $40.59
- Q2 FY26: reported $57.09 per share against an estimate of $41.75
FCNCA news
- Press releasePRNewswire
- Press releasePRNewswire
Halloween Budgets Top Thanksgiving: 38% Plan to Spend $300 or More, CIT Bank Survey Finds
- Press releasePRNewswire
First Citizens Bank Launches New Innovation Banking Brand
- Press releasePRNewswire
First Citizens BancShares, Inc. Announces Date of Third Quarter 2026 Earnings Call
- Press releasePRNewswire
CB Insights Joins Silicon Valley Bank's Partner Network to Give Innovators a Competitive Edge
- Press releasePRNewswire
First Citizens Bank Provides $157 Million to Morningstar Properties
- Press releasePRNewswire
First Citizens Bank Completes Branch Acquisition, Expanding Presence Across the Midwest, Great Plains and West
- Press releaseBusiness Wire
Money20/20 USA Unveils Expanded Startup Hub for Fintech's Rising Stars
Similar companies
Companies in the same industry as First Citizens BancShares Inc (Delaware)
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.